BDY Bradley Pharmaceuticals

NEW YORK, Feb. 21 /PRNewswire/ -- QED International Associates, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on Tuesday February 26, 2008, KV Pharmaceutical Co. (NYSE:KV.A) will replace Bradley Pharmaceuticals, Inc. (NYSE:BDY) in the HealthShares(TM) Dermatology and Wound Care Index. Bradley is being acquired by Nycomed US Inc., a subsidiary of Nycomed S.C.A., SICAR, a Zurich-based private pharmaceutical company. Companies included in the Dermatology and Wound Care Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of skin disorders by topical or systemic means. About QED International Associates QED International Associates, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com/ DATASOURCE: QED International Associates, Inc. CONTACT: Ed Matluck, CEO, or Michael Carty, Senior Advisor, both for QED International Associates: +1-212-953-4058, Web site: http://www.qedinternational.com/

Copyright